Cryo-Cell International Inc. (CCEL)
Cryo-Cell International Inc. is a biotechnology company specializing in cord blood and tissue banking services. Founded in 1989, it provides families with the option to store stem cell-rich cord blood and tissue for potential future medical treatments. The company operates internationally, offering processing, storage, and preservation of cord blood units for use in regenerative medicine and hematopoietic stem cell transplants.
Dividend History
| Pay Date | Amount | Ex-Date | Record Date |
|---|---|---|---|
| May 30, 2025 | $0.15 | 2025-05-21 | 2025-05-21 |
| February 28, 2025 | $0.25 | 2025-02-14 | 2025-02-14 |
| November 29, 2024 | $0.25 | 2024-11-15 | 2024-11-15 |
Dividends Summary
- Cryo-Cell International Inc. has issued 3 dividend payments over the past 1 years
- The most recent dividend was paid 113 days ago, on May 30, 2025
- The highest dividend payed out to investors during this period was $0.25 per share
- The average dividend paid during this period was $0.22 per share.
Company News
The global stem cell banking market is projected to reach $18.65 billion by 2031, growing at a CAGR of 18.30% due to advancements in cryopreservation, cell bank preparation, and the rising adoption of stem cell therapy. The market is driven by increased awareness of stem cell therapy, growing healthcare investments, and trends in personalized medicine.
The global stem cell banking market is expected to reach a value of USD 18.65 Billion by 2031, growing at a CAGR of 18.30% during the forecast period. The market is driven by advancements in cryopreservation, increased application of stem cell treatments, and the trend of late parenting leading to interest in cord blood banking.